SYSCHEMPharmaceuticals
Syschem India Ltd — Cash Flow Statement
₹41.32
-4.46%
Syschem India Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | -31.81 Cr | -32.33 Cr | -10.45 Cr | -3.34 Cr | — |
| Issuance Of Capital Stock | 33.87 Cr | 31.89 Cr | 10.73 Cr | — | — |
| Capital Expenditure | -21.72 Cr | -6.68 Cr | -1.96 Cr | -4.41 Cr | — |
| End Cash Position | 2.14 Cr | 0.10 Cr | 0.57 Cr | 0.03 Cr | — |
| Beginning Cash Position | 0.10 Cr | 0.57 Cr | 0.03 Cr | 0.02 Cr | — |
| Changes In Cash | 2.04 Cr | -0.48 Cr | 0.54 Cr | 33000.00 | — |
| Financing Cash Flow | 33.81 Cr | 31.64 Cr | 10.69 Cr | -0.28 Cr | — |
| Interest Paid Cff | -0.07 Cr | -0.25 Cr | -0.04 Cr | -0.28 Cr | — |
| Net Common Stock Issuance | 33.87 Cr | 31.89 Cr | 10.73 Cr | — | — |
| Common Stock Issuance | 33.87 Cr | 31.89 Cr | 10.73 Cr | — | — |
| Investing Cash Flow | -21.67 Cr | -6.46 Cr | -1.65 Cr | -0.78 Cr | — |
| Interest Received Cfi | 0.02 Cr | 0.11 Cr | 0.05 Cr | 0.07 Cr | — |
| Net Investment Purchase And Sale | -1000.00 | 0.09 Cr | 0.26 Cr | 1.05 Cr | — |
| Net PPE Purchase And Sale | -21.69 Cr | -6.67 Cr | -1.96 Cr | -3.43 Cr | — |
| Sale Of PPE | 0.03 Cr | 0.02 Cr | 0.00 | 0.98 Cr | — |
| Purchase Of PPE | -21.72 Cr | -6.68 Cr | -1.96 Cr | -4.41 Cr | — |
| Operating Cash Flow | -10.09 Cr | -25.65 Cr | -8.49 Cr | 1.07 Cr | — |
| Taxes Refund Paid | -0.55 Cr | -1.35 Cr | -1.64 Cr | 0.47 Cr | — |
| Change In Working Capital | -13.56 Cr | -31.34 Cr | -15.82 Cr | -0.01 Cr | — |
| Change In Payable | 18.90 Cr | 36.66 Cr | 17.54 Cr | -17.18 Cr | — |
| Change In Inventory | -16.88 Cr | -35.88 Cr | 3.62 Cr | 14.12 Cr | — |
| Change In Receivables | -15.58 Cr | -32.12 Cr | -36.99 Cr | 3.04 Cr | — |
| Other Non Cash Items | 0.05 Cr | 0.14 Cr | -62000.00 | 0.21 Cr | — |
| Depreciation And Amortization | 2.95 Cr | 2.79 Cr | 2.70 Cr | 2.58 Cr | — |
| Depreciation | 2.95 Cr | 2.79 Cr | 2.70 Cr | 2.50 Cr | — |
| Gain Loss On Sale Of PPE | 0.01 Cr | 28000.00 | 0.00 | 0.00 | — |
| Net Income From Continuing Operations | 1.01 Cr | 4.11 Cr | 6.15 Cr | -2.17 Cr | — |
| Provisionand Write Offof Assets | — | 0.00 | 0.12 Cr | — | — |
| Pension And Employee Benefit Expense | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash Adjustment Outside Changein Cash | — | — | 1000.00 | — | 2000.00 |
| Net Other Investing Changes | — | — | 10.73 Cr | 1.52 Cr | 2.68 Cr |
| Stock Based Compensation | — | — | 0.00 | 0.00 | 0.00 |
| Amortization Cash Flow | — | — | 0.06 Cr | 0.08 Cr | 0.08 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Syschem India Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.